SEC Form 4 · accession 0001104659-18-018386
Amphastar Pharmaceuticals, Inc. · AMPH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jason B. Shandell
Officer — President and General Counsel · Director
Period of report
Mar 15, 2018
Accepted (ET)
Mar 16, 2018 · 6:14 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001297184
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Mar 15, 2018 | A | 39,919 | $0.00 | A | 256,867 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F2 | $19.79 | Mar 15, 2018 | A | 92,692 | A | — | Mar 15, 2028 | Common Stock | 92,692 | 92,692 | D |
Explanation of responses
- F1The reported shares are represented by restricted stock units, or RSUs, which vest in four equal annual installments beginning on March 15, 2019.
- F2Shares subject to the option vest in four equal annual installments beginning on March 15, 2019.